We're investing over £280,000 to accelerate the development of new Parkinson's drugs
Date
News
Date
We're providing £1.6m through our Virtual Biotech programme to develop a potential new treatment targeting mitochondria to protect brain cells in Parkinson's patients.
Date
A partnership involving Parkinson's UK has been recognised at the Made with Patients awards, organised by Patient Focused Medicines Development.
Date
Campaigners are calling for the prescription charge exemption list in England to be reviewed following the price rise.
Date
We're providing £2.1million through our Virtual Biotech programme to develop a potential new drug which holds promise for protecting brain cells in Parkinson's.
Date
Tuesday 23 April is World Table Tennis Day, a celebration of all things table tennis. We spoke to members of the Parkinson's community about their experiences of playing table tennis and how it helps them to manage their symptoms.
Date
The TOP HAT trial is closing early and we have an important update on next steps.
Date
Parkinson's UK has funded two future leaders in Parkinson's research who are pushing forward our understanding of the early stages and causes of Parkinson's.
Date
Early research shows transplanting gut bacteria from healthy individuals to people with Parkinson's, called a faecal microbiota transplant, is safe and may ease motor symptoms.
Date
Lixisenatide, a diabetes drug being investigated for Parkinson's, shows potential to slow the progression of movement symptoms.
Date
New research study shows impact of delirium for people with Parkinson's in hospital